Why Is Clover Health And Wellness (CLOV) Stock Up Today? Director Chelsea Clinton bought 100,000 shares of CLOV stock 

Right now, investors of Clover Wellness (NASDAQ: CLOV) are smiling ear to ear. Although clov stock chart stays down more than 25% year-to-date (YTD), shares of the company are up over 20% today.

Why precisely is Clover Wellness trading greater now?

Over the weekend, it was reported that Clover director Chelsea Clinton had lately bought shares of CLOV stock. The purchase, which happened on March 3, saw Clinton acquire 100,000 shares for an average rate of $2.52 per share. In overall, Clinton’s current transaction amounted to $252,530, according to a Type 4 submitted to the united state Securities and Exchange Commission (SEC).

Why Is CLOV Stock Up Today?
Now, CLOV stock is up in response to Clinton’s purchase, which financiers are viewing as a favorable signal. Most of the times, supervisor trading activity like this is necessary to track due to the fact that insiders usually have a better view of a company’s long-lasting growth potential than retail investors.

So, with that said in mind, are other experts of Clover bullish on the firm? In the past twelve month, experts have purchased 2.2 million shares and sold 22.9 million shares. That’s a web of 20.6 million shares offered. This mass expert marketing appears to correlate with CLOV stock’s decrease of more than 60% over the past one year.

Still, with Clinton’s recent acquisition, capitalists are questioning that else is wagering big on Clover Health. Allow’s leap right in.

Who Else Is Betting Big on Clover Health?
Since the fourth quarter, 160 institutional financiers very own shares of CLOV stock. That notes a quarter-0ver-quarter (QOQ) boost of 8.8%. During the duration, the total quantity of shares held by institutional capitalists additionally enhanced from 105.7 million to 129.8 million, up virtually 23% QOQ. Let’s take a look on top five institutional shareholders.

Lead has 25.9 million shares or 7.65% ownership. The company purchased 8.8 million shares during Q4.
Greenoaks Funding Partners owns 24.8 million shares or 7.34% ownership. The firm sold 24.8 million shares during Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The firm acquired 2.6 million shares during Q4.
Two Sigma Investments has 6.6 million shares or 1.95% ownership. The firm acquired all 6.6 million shares throughout Q4.
PNC Financial Solutions (NYSE: PNC) owns 6.4 million shares or 1.88% possession. The firm sold 249,850 shares throughout Q4.
Out of the top five shareholders, 3 funds reduced their positions and also 2 funds enhanced their settings. Greenoaks Resources Allies had the most noteworthy purchase, as the fund marketed concerning 50% of its existing placement throughout Q4. Two Sigma’s 6.6 million share acquisition was also significant, as the procurement placed it among the top 5 shareholders.